© BioMed Central Ltd 2002
Published: 14 November 2002
Rett syndrome, a severe mental retardation disorder, is associated with mutations in the gene encoding methyl-CpG-binding protein-2 (MECP2). In the Early Edition of the Proceedings of the National Academy of Sciences Tudor et al. describe transcriptional profile analysis of brains from mice with a brain-specific deletion of the Mecp2 gene. Mecp2 deficiency was predicted to result is dramatic changes in global gene expression, but this turns out not be the case. Extensive statistical analysis of the microarray data revealed very few changes in gene expression, even in mutant mice displaying overt physiological symptoms. RNase protection experiments confirmed that a small number of genes change only slightly in mutant mouse brains. Tudor et al. speculate that neurons may be sensitive to relatively subtle changes in gene expression, or that the Mecp2 deletion affects a small subset of cells in the brain, or that there is a functional redundancy with other methyl-binding proteins.
- Rett syndrome; RTT, [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=312750]
- Methyl-CpG-binging protein 2; MECP2, [http://www.ncbi.nlm.nih.gov:80/entrez/dispomim.cgi?id=300005]
- Proceedings of the National Academy of Sciences, [http://www.pnas.org]
- Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain, [http://www.pnas.org/cgi/doi/10.1073/pnas.242566899]
- Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.